![Myrexis, Inc. logo](/news-release/logo/220136/0/220136.jpg?lastModified=12%2F10%2F2016%2005%3A59%3A41&size=2)
Myrexis, Inc. Announces the Cancellation of Its Upcoming Shareholder Meeting
January 23, 2013 09:00 ET
|
Myrexis, Inc.
Board Approves a Special Cash Distribution and the Appointment of a New Director and Chief Executive Officer
Tax Benefits Preservation Rights Plan Remains in Effect
SALT LAKE CITY, Jan. 23,...
![Myrexis, Inc. logo](/news-release/logo/220136/0/220136.jpg?lastModified=12%2F10%2F2016%2005%3A59%3A41&size=2)
Myrexis, Inc. Announces Board Approval of Plan of Complete Liquidation and Dissolution
November 09, 2012 16:03 ET
|
Myrexis, Inc.
SALT LAKE CITY, Nov. 9, 2012 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX) today announced that its Board of Directors has determined, after extensive and careful consideration of potential...
![Myrexis, Inc. logo](/news-release/logo/220136/0/220136.jpg?lastModified=12%2F10%2F2016%2005%3A59%3A41&size=2)
Myrexis Reports Fiscal Year 2012 Results and Provides Company Update
September 13, 2012 16:20 ET
|
Myrexis, Inc.
SALT LAKE CITY, Sept. 13, 2012 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX), today provided an update on recent developments and reported results for its fiscal full year ended June 30,...
![Myrexis, Inc. logo](/news-release/logo/220136/0/220136.jpg?lastModified=12%2F10%2F2016%2005%3A59%3A41&size=2)
Myrexis Appoints New Executive Management Team in Alignment With Strategic Initiatives
May 11, 2012 08:00 ET
|
Myrexis, Inc.
SALT LAKE CITY, May 11, 2012 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX) announced today that its Board of Directors has appointed Richard B. Brewer as President and Chief Executive Officer, and...
![Myrexis, Inc. logo](/news-release/logo/220136/0/220136.jpg?lastModified=12%2F10%2F2016%2005%3A59%3A41&size=2)
Myrexis Reports Third Quarter Fiscal Year 2012 Results
May 10, 2012 16:15 ET
|
Myrexis, Inc.
SALT LAKE CITY, May 10, 2012 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX) today reported financial results for its third fiscal quarter ended March 31, 2012.
As announced previously in February...
![Myrexis, Inc. logo](/news-release/logo/220136/0/220136.jpg?lastModified=12%2F10%2F2016%2005%3A59%3A41&size=2)
Myrexis Adopts Tax Benefits Preservation Rights Plan to Protect Use of Net Operating Losses Replacing Existing Shareholder Rights Plan
March 30, 2012 08:30 ET
|
Myrexis, Inc.
SALT LAKE CITY, March 30, 2012 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX) announced today that its Board of Directors has adopted a Tax Benefits Preservation Rights Plan in the form of a Rights...
![Myrexis, Inc. logo](/news-release/logo/220136/0/220136.jpg?lastModified=12%2F10%2F2016%2005%3A59%3A41&size=2)
Myrexis Initiates Resource Alignment
March 01, 2012 12:00 ET
|
Myrexis, Inc.
SALT LAKE CITY, March 1, 2012 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX) today announced that it has initiated an alignment of its resources including a reduction in force consistent with its...
![Myrexis, Inc. logo](/news-release/logo/220136/0/220136.jpg?lastModified=12%2F10%2F2016%2005%3A59%3A41&size=2)
Myrexis Retains Investment Bank to Explore Strategic Alternatives
February 15, 2012 12:17 ET
|
Myrexis, Inc.
SALT LAKE CITY, Feb. 15, 2012 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX), a biotechnology company focused on the development of small molecule therapeutics, today announced that its Board of...
![Myrexis, Inc. logo](/news-release/logo/220136/0/220136.jpg?lastModified=12%2F10%2F2016%2005%3A59%3A41&size=2)
Myrexis Reports Second Quarter Fiscal Year 2012 Results
February 09, 2012 16:15 ET
|
Myrexis, Inc.
SALT LAKE CITY, Feb. 9, 2012 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX), a biotechnology company focused on the development of small molecule therapeutics with novel chemical structures and...
![Myrexis, Inc. logo](/news-release/logo/220136/0/220136.jpg?lastModified=12%2F10%2F2016%2005%3A59%3A41&size=2)
Myrexis to Hold Conference Call to Discuss Second Fiscal Quarter 2012 Financial Results
February 03, 2012 08:30 ET
|
Myrexis, Inc.
SALT LAKE CITY, Feb. 3, 2012 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX), a biotechnology company focused on the development of small molecule compounds with novel chemical structures and distinct...